Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 inhibitors. Part 1

Autor: Haffner, Curt D., Thomson, Stephen A., Guo, Yu, Schaller, Lee T., Boggs, Sharon, Dickerson, Scott, Gobel, Jeff, Gillie, Dan, Condreay, J. Patrick

Publikováno v: In Bioorganic & Medicinal Chemistry Letters 2010 20(23):6983-6988

N-Hydroxyformamide peptidomimetics as TACE/Matrix metalloprotease inhibitors: oral activity via P1′ isobutyl substitution

Autor: Musso, David L., Andersen, Marc W., Andrews, Robert C., Austin, Richard, Beaudet, Elizabeth J., Becherer, J.David, Bubacz, Dulce G., Bickett, D.Mark, Chan, Joseph H., Conway, James G., Cowan, David J., Gaul, Michael D., Glennon, Kimberly C., Hedeen, Kevin M., Lambert, Millard H., Leesnitzer, M.Anthony, McDougald, Darryl L., Mitchell, Justin L., Moss, Marcia L., Rabinowitz, Michael H., Rizzolio, Michele C., Schaller, Lee T., Stanford, Jennifer B., Tippin, Timothy K., Warner, Janet R., Whitesell, L.Graham, Wiethe, Robert W.

Publikováno v: In Bioorganic & Medicinal Chemistry Letters 2001 11(16):2147-2151

Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor

Autor: Ferris, Robert G., Hazen, Richard J., Roberts, Grace B., St. Clair, Marty H., Chan, Joseph H., Romines, Karen R., Freeman, George A., Tidwell, Jeffrey H., Schaller, Lee T., Cowan, Jill R., Short, Steven A., Weaver, Kurt L., Selleseth, Dean W., Moniri, Kelly R., Boone, Lawrence R.

Publikováno v: Antimicrobial Agents and Chemotherapy; October 2005, Vol. 49 Issue: 10 p4046-4051, 6p

Optimizing Ligand Efficiency of Selective Androgen Receptor Modulators (SARMs).

Autor: Handlon AL; Metabolic Pathways Cardiovascular Unit and Platform Technology & Science, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406-0939, United States., Schaller LT; Metabolic Pathways Cardiovascular Unit and Platform Technology & Science, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406-0939, United States., Leesnitzer LM; Metabolic Pathways Cardiovascular Unit and Platform Technology & Science, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406-0939, United States., Merrihew RV; Metabolic Pathways Cardiovascular Unit and Platform Technology & Science, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406-0939, United States., Poole C; Metabolic Pathways Cardiovascular Unit and Platform Technology & Science, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406-0939, United States., Ulrich JC; Metabolic Pathways Cardiovascular Unit and Platform Technology & Science, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406-0939, United States., Wilson JW; Metabolic Pathways Cardiovascular Unit and Platform Technology & Science, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406-0939, United States., Cadilla R; Metabolic Pathways Cardiovascular Unit and Platform Technology & Science, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406-0939, United States., Turnbull P; Metabolic Pathways Cardiovascular Unit and Platform Technology & Science, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406-0939, United States.

Publikováno v: ACS medicinal chemistry letters [ACS Med Chem Lett] 2015 Nov 19; Vol. 7 (1), pp. 83-8. Date of Electronic Publication: 2015 Nov 19 (Print Publication: 2016).